Generic substitution: A potential risk factor for medication errors in hospitals

Advances in Therapy

Volumn 27, Issue 2, 2010, Pages 118-126

  Håkonsen, Helle ^a   Hopen, Heidi Skjønhaug ^a   Abelsen, Linda ^b   Ek, Bjørg ^c   Toverud, Else Lydia ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Ostfold Hospital Trust   (Norway)

^c Hospital Pharmacy Fredrikstad   (Norway)

Author keywords

Competitive tendering; Cost containment; Generic drugs; Generic substitution; Hospital; Medication error; Nurse; Patient safety

Indexed keywords

CEFALEXIN; CEFALOTIN; CEFOTAXIME; ENALAPRIL; GENERIC DRUG; LISINOPRIL; METFORMIN; METOPROLOL TARTRATE; NITRAZEPAM; OXAZEPAM; RAMIPRIL;

ADULT; ARTICLE; COST CONTROL; DOCTOR NURSE RELATION; DRUG COST; DRUG NOMENCLATURE; FEMALE; HOSPITAL MANAGEMENT; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MEDICAL DOCUMENTATION; MEDICATION ERROR; NORMAL HUMAN; NORWAY; NURSE ATTITUDE; NURSE TRAINING; NURSING STAFF; PATIENT SAFETY; PHARMACEUTICAL CARE; PRESCRIPTION; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEMI STRUCTURED INTERVIEW; WORKLOAD;

ADULT; ATTITUDE OF HEALTH PERSONNEL; DRUGS, GENERIC; FEMALE; HUMANS; MALE; MEDICATION ERRORS; MEDICATION SYSTEMS, HOSPITAL; MIDDLE AGED; NORWAY; NURSING STAFF, HOSPITAL; RISK FACTORS; TERMINOLOGY AS TOPIC; WORKLOAD;

EID: 77953002754     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0007-8     Document Type: Article

References (29)

1. Ess SM, Schneeweiss S, Szucs TD. European healthcare policies for controlling drug expenditure. Pharmacoeconomics. 2003;21:89-103.
2. Håkonsen H, Horn AM, Toverud EL. Price control as a strategy for pharmaceutical cost containment- what has been achieved in Norway in the period 1994-2004? Health Policy. 2009;90:277-285.
3. The Norwegian Association of Pharmaceutical Manufacturers. Facts and Figures 2009. Available at: www.legemiddelstatistikk.com/tf/2009/english/chap-2/ 203.html. Accessed January 20, 2010.
4. LIS (Drug Procurement Cooperation). Annual report 2008. Available at: www.lisnorway.no/lisnorway/vedlegg/LIS-RHF-rapport-2008-til-hjemmesiden-Rev-29. 06-KRF.doc. Accessed January 20, 2010.
5. Ministry of Health and Care Services. FOR-2008-04-03-320: Forskrift om legemiddelhåndtering for virksomheter og helsepersonell som yter helsehjelp [in Norwegian]. Oslo, Norway: Ministry of Health and Care Services; 2008.
6. Barker KN, Flynn EA, Pepper GA, Bates DW, Mikeal RL. Medication errors observed in 36 health care facilities. Arch Intern Med. 2002;162: 1897-1903.
7. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199-205.
8. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285:2114-2120.
9. Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30:379-407.
10. The National Coordinating Council for Medication Error Reporting and Prevention. What is a medication error? Available at: www.nccmerp.org/ aboutMedErrors.html. Accessed January 20, 2010.
11. Teigen IM, Rendum KL, Slørdal L, Spigset O. Medication errors in hospitalised patients [in Norwegian]. Tidsskr Nor Legeforen. 2009;129:1337-1341.
12. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997;277:306-311.
13. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
14. Kunac DL, Kennedy J, Austin N, Reith D. Incidence, preventability, and impact of adverse drug events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study. Pediatr Drugs. 2009;11:153-160.
15. Phillips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm. 2001;58:1835-1841.
16. Pinilla J, Murillo C, Carrasco G, Humet C. Case-control analysis of the financial cost of medication errors in hospitalized patients. Eur J Health Econ. 2006;7:66-71.
17. van den Bemt PMLA, Egberts TCG, de Jong-van den Berg LTW, Brouwers JRBJ. Drug-related problems in hospitalised patients. Drug Saf. 2000;22: 321-333.
18. Berman A. Reducing medication errors through naming, labeling, and packaging. J Med Syst. 2004;28:9-29.
19. Hoffman JM, Proulx SM. Medication errors caused by confusion of drug names. Drug Saf. 2003;26: 445-452.
20. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (Wash). 2000;40: 378-383.
21. Himmel W, Simmenroth-Nayda A, Niebling W, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43:472-479.
22. Håkonsen H, Eilertsen M, Borge H, Toverud EL. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin. 2009;25:2515-2521.
23. Kjoenniksen I, Lindbaek M, Granas AG. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28:284-289.
24. Nelson S, Slørdal L, Spigset O. Generic drugs instead of brand drugs prescriptions- long overdue [in Norwegian]. Tidsskr Nor Laegeforen. 2006;126:441- 443.
25. Fry MM, Dacey C. Factors contributing to incidents in medicine administration. Part 1. Br J Nurs. 2007;16:556-559.
26. Tang FI, Sheu SJ, Yu S, Wei IL, Chen CH. Nurses relate the contributing factors involved in medication errors. J Clin Nurs. 2007;16:447-457.
27. van Rosse F, Maat B, Rademaker CMA, van Vught AJ, Egberts ACG, Bollen CW. The effect of computerized physician order entry on medication prescription errors and clinical outcome in pediatric and intensive care: a systematic review. Pediatrics. 2009;123:1184-1190.
28. Heier KF, Olsen VK, Rognstad S, Straand J, Toverud EL. Healthcare providers' experience with multi-dose packaged medicines [in Norwegian]. Tidsskr Nor Laegeforen. 2007;127:2382-2385.
29. Bates DW, Miller EB, Cullen DJ, et al. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med. 1999;159:2553-2560.